We found an E. coli mutant of MG1655 in scientific literature from the University of Barcelona (Strain E-15 EG3), that is able to grow solely on ethylene glycol, one of the two products created during PET degradation [1]. The scientists in Barcelona created these mutants through directed evolution, a process that selects for the most fit in a group. Then, the scientists performed ethyl methylsulfonate (EMS) on the cultures, plated the cells on media with ethylene glycol, and restreaked the colonies several times. From this, they learned that the main contributors in the degradation were propanediol oxidoreductase and glycolaldehyde dehydrogenase. These two enzymes are expressed at low levels in MG1655 but not at all in DH5α. We want to overexpress these enzymes in MG1655 through directed strain engineering. Rather than take the enzymes from Strain E-15 EG3, we want to clone the enzymes from the MG1655 and be able to control them ourselves, also known as rational strain engineering.
Team:UC Davis/Project/Strain
From 2012.igem.org
(Difference between revisions)
Line 1,285: | Line 1,285: | ||
Our goal in the construction of the reductase and dehydrogenase assembly is to allow a modular system for simplified testing and use. In addition to the use of the modular system, the sequencing of Strain E-15 EG3 shows us the other mutations in the chromosome that allow it to be efficient. Putting these two pieces of information together specifies the region in the MG1655 chromosome that we want to overexpress or mutate for efficient degradation of ethylene glycol. | Our goal in the construction of the reductase and dehydrogenase assembly is to allow a modular system for simplified testing and use. In addition to the use of the modular system, the sequencing of Strain E-15 EG3 shows us the other mutations in the chromosome that allow it to be efficient. Putting these two pieces of information together specifies the region in the MG1655 chromosome that we want to overexpress or mutate for efficient degradation of ethylene glycol. | ||
<br> | <br> | ||
- | <img src="https://static.igem.org/mediawiki/2012/6/64/NaFx5cZLC_fH2TU4OSvWnBVEAZy_uurW8P0QrAzoAu0.jpeg"> | + | <img src="https://static.igem.org/mediawiki/2012/6/64/NaFx5cZLC_fH2TU4OSvWnBVEAZy_uurW8P0QrAzoAu0.jpeg" width=350> |
</article> | </article> | ||
</div> | </div> |
Revision as of 06:58, 3 October 2012
Chassis Engineering: Background
We found an E. coli mutant of MG1655 in scientific literature from the University of Barcelona (Strain E-15 EG3), that is able to grow solely on ethylene glycol, one of the two products created during PET degradation [1]. The scientists in Barcelona created these mutants through directed evolution, a process that selects for the most fit in a group. Then, the scientists performed ethyl methylsulfonate (EMS) on the cultures, plated the cells on media with ethylene glycol, and restreaked the colonies several times. From this, they learned that the main contributors in the degradation were propanediol oxidoreductase and glycolaldehyde dehydrogenase. These two enzymes are expressed at low levels in MG1655 but not at all in DH5α. We want to overexpress these enzymes in MG1655 through directed strain engineering. Rather than take the enzymes from Strain E-15 EG3, we want to clone the enzymes from the MG1655 and be able to control them ourselves, also known as rational strain engineering.
Rationale
Our main goal is for the E. coli to be able to live off PET as the sole carbon source. In order to do this, it must be able to sequester the carbon into its metabolism. In the diagram below, the ethylene glycol binds to the glycolaldehyde reductase to form glycolaldehyde. After, the glycolaldehyde attaches to the glycolaldehyde dehydrogenase to form glycolate. The glycolate goes in to the metabolism via further reactions with glycolate dehydrogenase and malate synthase. The (S)-malate is the final product that is incorporated in to the citric acid (TCA) cycle. As the citric acid cycle propagates, more energy is made for the cell, allowing growth and self-sufficient development on PET.
Our Strain
References
2. Bsc, S. N. and Gp Savage Bsc(hons), PhD, Nz Reg NutR. (1999), Oxalate content of foods and its effect on humans. Asia Pacific Journal of Clinical Nutrition, 8: 64–74. doi: 10.1046/j.1440-6047.1999.00038.x